Circulating miRNAs: reflecting or affecting cardiovascular disease?
about
Circulating microRNAs as mirrors of acute coronary syndromes: MiRacle or quagMire?Novel insights into miRNA in lung and heart inflammatory diseasesMethodological challenges in utilizing miRNAs as circulating biomarkersNoncoding RNA in age-related cardiovascular diseasesPeripheral blood miRNAs as a biomarker for chronic cardiovascular diseasesSynergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence.Small engine, big power: microRNAs as regulators of cardiac diseases and regeneration.Exercise: putting action into our epigenome.Detection and comparison of microRNA expression in the serum of Doberman Pinschers with dilated cardiomyopathy and healthy controls.Non-Coding RNAs: Functional Aspects and Diagnostic Utility in OncologyA deep sequencing approach to uncover the miRNOME in the human heart.Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina.Micro-RNAs Let7e and 126 in Plasma as Markers of Metabolic Dysfunction in 10 to 12 Years Old Children.Expression of circulating miR-486 and miR-150 in patients with acute myocardial infarction.MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients.Hyperglycemia Determines Increased Specific MicroRNAs Levels in Sera and HDL of Acute Coronary Syndrome Patients and Stimulates MicroRNAs Production in Human Macrophages.Detection of Differentially Expressed MicroRNAs in Rheumatic Heart Disease: miR-1183 and miR-1299 as Potential Diagnostic BiomarkersBlood microRNAs in low or no risk ischemic stroke patients.Predictors and prevention of diabetic cardiomyopathy.Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment.Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarctionUsing information theory to assess the communicative capacity of circulating microRNA.Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney diseaseNon-coding RNAs and hypertension-unveiling unexpected mechanisms of hypertension by the dark matter of the genomeCardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication.Microfluidic platforms for biomarker analysis.Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers.Circulating MicroRNAs and Life Expectancy Among Identical Twins.microRNAs in Cerebrovascular Disease.HDL and microRNA therapeutics in cardiovascular disease.MicroRNA miR-301a is a novel cardiac regulator of Cofilin-2.Circulating endothelial microparticles and miR-92a in acute myocardial infarctionNext generation sequencing applications for cardiovascular disease.Evaluation of epigenetic alterations (mir-126 and mir-155 expression levels) in Mexican children exposed to inorganic arsenic via drinking water.Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis.Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection.Plasma miR-208 as a useful biomarker for drug-induced cardiotoxicity in rats.Circulating MicroRNAs in Young Patients with Acute Coronary Syndrome.A Preliminary Study of microRNA-208b after Acute Myocardial Infarction: Impact on 6-Month Survival.
P2860
Q27001706-24A35C6B-5FA7-4789-9790-A74DDEA3E2D7Q27026348-B2187182-E08E-4E92-AA42-B69BEC334161Q27027950-DBE72317-E8D4-4CDF-B7B9-D647780C75ABQ28081466-78ED94FC-C0F0-4EC7-9BB2-85A608B46EB4Q33738059-C55273A5-7F8F-4686-82F5-35784C8FA8D1Q33739176-E9BC72C0-8253-4851-BC33-08671FFA858FQ34358827-F75FE976-5AB8-4894-8C16-1FF8C7653489Q34380487-36290B40-9A7B-418D-8801-F076C8099FA2Q34552832-EAC96195-9A32-4D41-9A52-0583ACD30350Q34605730-EF8147C6-D786-40B4-8055-84A21674A913Q34608849-D416AC2D-6CCD-4E0D-BE04-97B1B8C457B0Q35048954-62128194-7685-4FD5-AEAE-9EDEC4BE792DQ35653748-7AEE57FC-2A76-4D90-B094-B5F676799FE7Q35664601-10B2E070-7425-4401-8B00-ED3F60B3213DQ35814698-4BF97655-EBA3-4116-A9C1-030B8A1A8F80Q36102976-7852E4C4-F921-44CA-9C68-79E9BCC35AADQ36204131-E2476881-5103-4E52-9E2F-B767FA716BAAQ36590184-63DA9966-3F56-4187-8222-6A9D468EE217Q36776922-C1512A36-3045-4DB5-A8FB-DE3B63D459FCQ36926187-D336FCD0-74AC-4500-BA6E-B4186D0DA3F2Q37516362-FF1FA471-FBD9-466B-B653-C0AD601DF198Q37543447-F3DB035B-791C-4042-9B86-C6C2BD5AD378Q37591528-759641B2-12C7-4CF7-9966-038983B594F8Q37741539-94012767-A1BA-4262-A9F4-658920F0A4EAQ38165939-6CB39F1E-30D5-4018-8FAE-00F1B9351DF9Q38198962-2394A150-A7B7-449D-895C-EC04D5912B5BQ38244277-ACBCABF9-C15B-4126-9370-C1B40ED45E2AQ38379285-226E90FC-3EFC-427E-AA3F-3CF017B47C90Q38668253-374E661B-6FBF-4860-BFDA-1FC98EAE964EQ38824208-4B45E2D3-A4BC-4882-92C3-9F2CCA723F5EQ41496727-354758F7-D970-4824-84AD-8B3B78F31C04Q42074198-31F5985E-93BB-4594-92BE-8A5A532A450BQ47805269-9F78B0AA-8AEC-49E8-98C5-8788DD5375E6Q47831231-6FDDEB15-AEB1-47B3-9382-6A86AB76364FQ51025922-F75B8919-E16F-4DE1-A1D9-2B1EC0CE46A8Q52589516-76EEB836-B5D5-4219-8664-89FDFE53948CQ54195804-C50B26FB-32FC-442B-8A9A-D5175C4539FAQ54959799-ADE74E46-E270-4E95-86D2-7B8B6108A59EQ55415874-1617DE3C-01E5-48C8-9772-5AB3B45DE137
P2860
Circulating miRNAs: reflecting or affecting cardiovascular disease?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Circulating miRNAs: reflecting or affecting cardiovascular disease?
@en
type
label
Circulating miRNAs: reflecting or affecting cardiovascular disease?
@en
prefLabel
Circulating miRNAs: reflecting or affecting cardiovascular disease?
@en
P2093
P2860
P1476
Circulating miRNAs: reflecting or affecting cardiovascular disease?
@en
P2093
Leon J De Windt
Paula A da Costa Martins
Vanessa P M van Empel
P2860
P2888
P304
P356
10.1007/S11906-012-0310-7
P577
2012-12-01T00:00:00Z
P5875
P6179
1006201606